International Patent: AUTOPHAGY INHIBITOR THAT TARGETS THE ATG14L-BECLIN1 PROTEIN-PROTEIN INTERACTION

GENEVA, Aug. 7 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES filed a patent application (US2025/050250) for “AUTOPHAGY INHIBITOR THAT TARGETS THE ATG14L-BECLIN1 PROTEIN-PROTEIN INTERACTION”. With publication no. WO/2026/080713, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61P 31/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....